Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$5.00 - $6.00

Shares Offered

1,000,000

Deal Size

$5.50M

Vitro Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	2021	2020
Net Income	-4.76	-1.64
Depreciation & Amortization	0.16	0.15
Share-Based Compensation	2.04	0.27
Other Operating Activities	1.32	0.36
Operating Cash Flow	-1	-0.78
Capital Expenditures	-0.03	-0.03
Acquisitions	0.37	-
Investing Cash Flow	0.34	-0.03
Share Issuance / Repurchase	1.79	1.03
Debt Issued / Paid	2.95	-0.04
Financing Cash Flow	4.74	0.98
Net Cash Flow	4.08	0.18
Free Cash Flow	-1.03	-0.81
Free Cash Flow Margin	-78.66%	-124.13%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).